Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin (Q46041069)
scientific article published in February 2008
Language:
Current Data About Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin
(P31) (Q13442814)
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

(P50) (Q46041139)
(P1932) Karen L Reckamp
(P1545) 1

(P304) 117-124
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

(P433) 2
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

(P478) 3
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

(P577) Friday, February 1, 2008
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

(P921) (Q418369)
(P887)

(P1433) (Q2448056)
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

(P1476) "Tumor response to combination celecoxib and erlotinib therapy in non-small cell lung cancer is associated with a low baseline matrix metalloproteinase-9 and a decline in serum-soluble E-cadherin" (language: en)
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

(P2093) Brian K Gardner
(P1545) 2
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

Robert A Figlin
(P1545) 3
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

David Elashoff
(P1545) 4
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

Kostyantyn Krysan
(P1545) 5
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

Mariam Dohadwala
(P1545) 6
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

Jenny Mao
(P1545) 7
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

Sherven Sharma
(P1545) 8
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

Landon Inge
(P1545) 9
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

Ayyappan Rajasekaran
(P1545) 10
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

Steven M Dubinett
(P1545) 11
(P248)
(P698) 18303430
(P813) Monday, December 18, 2017
(P854) http://europepmc.org/abstract/MED/18303430

other details
description scientific article published in February 2008

External Links
(P356) 10.1097/JTO.0B013E3181622BEF
(P698) 18303430